CNC
CENTENE CORP
NYSE · Healthcare · Medical - Healthcare Plans · US
$73.51
+8.93%Year over year
Reported trailing growth
- Revenue
- +4.8%
- EBITDA
- +230.6%
- EBIT
- +120.8%
- EPS
- +127.4%
- Free cash flow
- +18.0%
- Operating cash flow
- +16.7%
Forward estimates
Based on analyst estimates
- Revenue
- -0.6%
- EBITDA
- +40.5%
- EPS
- +77.6%
Three-year CAGR
- Revenue
- +10.5%
- EBITDA
- —
- EBIT
- —
- Net income
- —
- EPS
- —
- Free cash flow
- -6.3%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Sep 1, 2026